Breakthrough SARS-CoV-2 infections after vaccination: a critical review

Hum Vaccin Immunother. 2022 Nov 30;18(5):2051412. doi: 10.1080/21645515.2022.2051412. Epub 2022 Mar 18.

Abstract

At the beginning of the current pandemic, it was believed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection would induce lifelong immunity and that reinfections would be unlikely. However, after several cases of reinfection were documented in previously infected patients, this was understood to be a false assumption, and this waning humoral immunity has raised significant concerns. Accordingly, long-term and durable vaccine-induced antibody protection against infection have also become a challenge, as several breakthroughs of COVID-19 infection have been identified in individuals who were fully vaccinated. This review discusses the current evidence on breakthrough COVID-19 infections occurring after vaccination.

Keywords: COVID-19; SARS-CoV-2; breakthrough; immunization; vaccination.

Publication types

  • Review

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Reinfection / epidemiology
  • Reinfection / prevention & control
  • SARS-CoV-2
  • Vaccination
  • Viral Vaccines*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Viral Vaccines

Supplementary concepts

  • COVID-19 breakthrough infections

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.